Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Concord Drugs Share Price

Concord Drugs Ltd.

₹71

0.36(0.51%)

Trade Now

2nd Apr 2026 | 3:08 PM

NSE :

Open Free Demat Account

Concord Drugs Performance

Price Movement

N/A

₹69.07

₹72.80

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹72.80

Low₹69.07

Open at₹72.80

Prev Close₹70.64

Volumes2.36 K

Avg Price₹70.95

Lower Circuit₹67.11

Upper Circuit₹74.17

Historical Performance

3M High₹91.79

3M Low₹67.25

1 Yr High₹92.52

1 Yr Low₹29.00

3 Yr High₹92.52

3 Yr Low₹25.56

5 Yr High₹92.52

5 Yr Low₹19.50

Concord Drugs Fundamentals

Market Cap

Below industry Median

93.50 Cr.

PE Ratio (TTM)

High in industry

165.30

Dividend Yield

Net Profit TTM

1525.0% incr over last year

0.57

Net Profit Growth

1525.0% incr over last year

0.57

PEG Ratio

Below industry Median

0.10

ROE

30% decr over last year

0.98

Operating Revenue TTM

51.24

Operating Revenue Growth

1.5% incr over last year

Book Value

Above industry Median

2.50

MFI

MFI oversold

24.16

RSI

RSI is mid-range

41.70

EPS (TTM)

0.34

Debt to Equity

0.50

Face Value

Operating Profit Margin Qtr.

9.13

Operating Profit Qtr.

0.92

Net Profit Qtr.

0.22

Operating Revenue Qtr.

16.97

PB Ratio

2.50

Concord Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	16.84	10.07	13.38	7.96	10.77
Operating Expense	15.97	9.21	12.45	7.04	9.46
Operating Profit	0.87	0.87	0.94	0.92	1.31
Depreciation	0.30	0.34	0.37	0.37	0.37
Interest	0.30	0.40	0.42	0.53	0.43
Tax	0.08	0.04	0.04	0.01	0.30
Net Profit	0.22	0.09	0.11	0.01	0.22

Concord Drugs Technicals

Concord Drugs Ltd. EMA & SMA

₹71.00

0.36 (0.51%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹71.1

Day EMA10 ₹72

Day EMA12 ₹72.3

Day EMA20 ₹73.4

Day EMA26 ₹74.2

Day EMA50 ₹75.8

Day EMA100 ₹75

Day EMA200 ₹68.3

Concord Drugs Support and Resistance

Resistance

First Resistance₹72.84

Second Resistance₹74.69

Third Resistance₹76.57

Support

First Support₹69.11

Second Support₹67.23

Third Support₹65.38

Technical Indicators

Day RSI41.70

Day MFI24.16

Day ADX12.10

Day Commodity Channel Index-95.00

William-73.87

Day MACD-1.88

Day MACD Signal Line-1.71

Day ATR4.35

Day ROC1258.56

Day ROC21-10.13

Concord Drugs Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	54.4	54.4	54.4	54.4	54.4	54.4
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	45.6	45.6	45.6	45.6	45.6	45.6

Concord Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.7 K	2.02 K	84.20%
Week	1.64 K	1.9 K	86.44%
1 Month	3.49 K	4.22 K	82.73%
6 Month	7.25 K	9.16 K	79.10%

Concord Drugs SWOT Analysis

Strengths8

Weakness9

Opportunity0

Threats0

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Increasing profits every quarter for the past 3 quarters

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Top Gainers

Concord Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Concord Drugs Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹201.95	₹37.60	₹5.80	₹89.80	₹345.05	₹108.50
% Change	-1.49%	1.98%	4.88%	-10.11%	-0.00%	2.54%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	56.00	-95.60	-1.40	11.90	76.40	27.40
1 Year Return		735.56	479	-29.73		-14.23
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.60

-0.42%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.20

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 59.50

+2.06%

APL

Asston Pharmaceuticals Ltd.

₹ 78.00

-1.02%

INFLUX

Influx Healthtech Ltd.

₹ 214.00

+0.19%

MEDIORG

Medicamen Organics Ltd.

₹ 23.25

+4.97%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 507.95

+1.69%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 31.79

+4.61%

SENORES

Senores Pharmaceuticals Ltd.

₹ 785.00

+1.48%

INNOVACAP

Innova Captab Ltd.

₹ 703.90

-0.01%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 56.10

-1.48%

SHELTER

Shelter Pharma Ltd.

₹ 29.35

-1.44%

TLL

Trident Lifeline Ltd.

₹ 263.50

-1.03%

DPL

Dipna Pharmachem Ltd.

₹ 9.00

-2.70%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.65

+0.53%

FABINO

Fabino Enterprises Ltd.

₹ 16.73

+4.96%

SUPRIYA

Supriya Lifescience Ltd.

₹ 611.00

+1.66%

SIGACHI

Sigachi Industries Ltd.

₹ 19.45

-0.10%

WINDLAS

Windlas Biotech Ltd.

₹ 766.00

-0.21%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+0.10%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 474.80

+3.42%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+2.27%

FAQ's on CONCORD

What is the Market Capitalization of Concord Drugs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Concord Drugs Ltd. is approximately ₹ 93.5 Cr.

What are the PE and PB ratios for Concord Drugs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Concord Drugs Ltd. is 165.3, and the Price-to-Book (PB) ratio is 2.5.

What is the 52-Week High and Low for Concord Drugs Ltd.?

Over the past 52 weeks, the highest price reached by Concord Drugs Ltd. shares was ₹ 92.52, and the lowest price was ₹ 29.

Who are the major shareholders of Concord Drugs Ltd.?

Significant shareholdings in Concord Drugs Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Concord Drugs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Concord Drugs Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy